NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
Authors
Keywords
-
Journal
Diabetology & Metabolic Syndrome
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-14
DOI
10.1186/s13098-020-00570-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects with Hepatic Steatosis
- (2020) Malte P. Suppli et al. DIABETES
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes
- (2020) Kenneth Cusi DIABETES CARE
- Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
- (2020) Robert Ross et al. Nature Reviews Endocrinology
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Diagnostic Accuracy of Non-Invasive Fibrosis Models to Detect Change in Fibrosis Stage
- (2019) M. Shadab Siddiqui et al. Clinical Gastroenterology and Hepatology
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Dipeptidyl Peptidase 4 Activity Is Related to Body Composition, Measures of Adiposity, and Insulin Resistance in Subjects with Excessive Adiposity and Different Degrees of Glucose Tolerance
- (2019) Wellington S. Silva Júnior et al. Journal of Diabetes Research
- The liver-alpha cell axis and type 2 diabetes
- (2019) Nicolai J Wewer Albrechtsen et al. ENDOCRINE REVIEWS
- The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
- (2019) Arun J. Sanyal et al. HEPATOLOGY
- Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
- (2019) Philip Newsome et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and Obesity Treatment
- (2019) Katherine T. Brunner et al. Current Obesity Reports
- Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
- (2019) Thomas Marjot et al. ENDOCRINE REVIEWS
- Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes
- (2018) Nicolai J. Wewer Albrechtsen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The Global Epidemic of the Metabolic Syndrome
- (2018) Mohammad G. Saklayen CURRENT HYPERTENSION REPORTS
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids
- (2018) Nicolai J. Wewer Albrechtsen et al. DIABETOLOGIA
- Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
- (2018) Jan W. Eriksson et al. DIABETOLOGIA
- EJE PRIZE 2018: A gut feeling about glucagon
- (2018) Filip K Knop EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
- (2018) Eeva Sliz et al. HUMAN MOLECULAR GENETICS
- Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
- (2018) Boyu Li et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Pharmacotherapy of type 2 diabetes: An update
- (2018) Jagriti Upadhyay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30–35 kg/m 2 )
- (2018) Ali Aminian et al. Surgery for Obesity and Related Diseases
- Mediterranean diet and nonalcoholic fatty liver disease
- (2018) Caterina Anania et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2018) Masanori Shimizu et al. DIABETES OBESITY & METABOLISM
- Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial
- (2018) Naveed Sattar et al. DIABETOLOGIA
- Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease
- (2018) Jian-Hui Yan et al. MEDICINE
- Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
- (2018) Devram S. Ghorpade et al. NATURE
- Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
- (2018) Simona Leoni et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy
- (2018) Amelio F. Godoy-Matos et al. Diabetology & Metabolic Syndrome
- Impact of SGLT2 inhibitor to histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus
- (2018) Norio Akuta et al. HEPATOLOGY RESEARCH
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis
- (2018) Tannous K. Fakhry et al. Surgery for Obesity and Related Diseases
- Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
- (2018) Vlad Ratziu et al. TRANSPLANTATION
- Dipeptidyl peptidase 4 (DPP4), adipose inflammation, and insulin resistance: is it time to look to the hepatocyte?
- (2018) Wellington S. Silva Júnior et al. HEPATOBILIARY SURGERY AND NUTRITION
- Short article
- (2017) Xiao-Long Deng et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
- (2017) Charlie C. Park et al. GASTROENTEROLOGY
- Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit
- (2017) Yaron Rotman et al. HEPATOLOGY
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease
- (2017) Fernando Bril et al. HEPATOLOGY
- A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation
- (2017) Iram Hussain et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population
- (2017) Raxitkumar Jinjuvadia et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms
- (2017) Shira Zelber-Sagi et al. LIVER INTERNATIONAL
- Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- (2017) Wenjie Dai et al. MEDICINE
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35–3 Years of Follow-Up
- (2017) Marcos A. Berry et al. OBESITY SURGERY
- Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass—results of a randomized clinical trial
- (2017) Piotr Kalinowski et al. Surgery for Obesity and Related Diseases
- Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
- (2017) Brandon J Perumpail et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
- (2017) Hironori Kitade et al. Nutrients
- Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012
- (2017) Justin Xavier Moore et al. Preventing Chronic Disease
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease
- (2016) Donghee Kim et al. Clinical Gastroenterology and Hepatology
- Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease
- (2016) William N. Hannah et al. Clinics in Liver Disease
- Inorganic Nitrate Mimics Exercise-Stimulated Muscular Fiber-Type Switching and Myokine and γ-Aminobutyric Acid Release
- (2016) Lee D. Roberts et al. DIABETES
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
- (2016) Francesco Rubino et al. DIABETES CARE
- Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues
- (2016) Vanessa Pellegrinelli et al. DIABETOLOGIA
- Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study
- (2016) Amalia Gastaldelli et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia
- (2016) A. E. Junker et al. JOURNAL OF INTERNAL MEDICINE
- Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial
- (2016) G. Misciagna et al. Journal of Nutrition Health & Aging
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance
- (2016) Luca A Lotta et al. NATURE GENETICS
- The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2016) Jesse Clanton et al. SURGICAL CLINICS OF NORTH AMERICA
- Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter
- (2016) Anita Arslanow et al. Clinical and Translational Gastroenterology
- Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis
- (2015) Niraj S. Patel et al. Clinical Gastroenterology and Hepatology
- Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies
- (2015) Wenjuan Tang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids
- (2015) Bianca M. Arendt et al. HEPATOLOGY
- Effect of Vildagliptin on Hepatic Steatosis
- (2015) Mavin Macauley et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
- (2015) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Guidelines for Obesity Management in Adults
- (2015) Volkan Yumuk et al. Obesity Facts
- Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
- (2015) Wellington Santana da Silva Júnior et al. Biomed Research International
- Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease
- (2014) Robert Caiazzo et al. ANNALS OF SURGERY
- SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis
- (2014) Fen Xu et al. DIABETES
- No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
- (2014) Arun J. Sanyal et al. GASTROENTEROLOGY
- Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
- (2014) Rohit Loomba et al. HEPATOLOGY
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) Gerald I. Shulman NEW ENGLAND JOURNAL OF MEDICINE
- Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2014) Yoshio Sumida WORLD JOURNAL OF GASTROENTEROLOGY
- The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies
- (2014) Jana V van Vliet-Ostaptchouk et al. BMC Endocrine Disorders
- The role of glucagon on type 2 diabetes at a glance
- (2014) Amélio F Godoy-Matos Diabetology & Metabolic Syndrome
- Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery
- (2014) David E Cummings et al. Lancet Diabetes & Endocrinology
- Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
- (2013) Y Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
- (2013) Meropi D. Kontogianni et al. CLINICAL NUTRITION
- Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin
- (2013) Pamela Maffioli et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
- (2013) Marno C. Ryan et al. JOURNAL OF HEPATOLOGY
- GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK
- (2013) Lili Zhang et al. LIVER INTERNATIONAL
- Dipeptidyl peptidase-4: A key player in chronic liver disease
- (2013) Minoru Itou WORLD JOURNAL OF GASTROENTEROLOGY
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Liver-Specific Disruption of the Murine Glucagon Receptor Produces -Cell Hyperplasia: Evidence for a Circulating -Cell Growth Factor
- (2012) C. Longuet et al. DIABETES
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity
- (2011) F. K. Knop et al. DIABETES OBESITY & METABOLISM
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
- (2011) Ruben Hernaez et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Polyunsaturated Fatty Acids Selectively Suppress Sterol Regulatory Element-binding Protein-1 through Proteolytic Processing and Autoloop Regulatory Circuit
- (2010) Yoshinori Takeuchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: A break of intestinal insulin resistance?
- (2010) Natalia N. Rudovich et al. JOURNAL OF HEPATOLOGY
- Diets with High or Low Protein Content and Glycemic Index for Weight-Loss Maintenance
- (2010) Thomas Meinert Larsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efeito da perda ponderal induzida pela cirurgia bariátrica sobre a prevalência de síndrome metabólica
- (2009) Francisco das Chagas Monteiro Júnior et al. Arquivos Brasileiros de Cardiologia
- Rosiglitazone decreases intra- to extramyocellular fat ratio in obese non-diabetic adults with metabolic syndrome
- (2009) A. F. Godoy-Matos et al. DIABETIC MEDICINE
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
- (2009) Anna Kotronen et al. GASTROENTEROLOGY
- Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
- (2009) Yuichi Nozaki et al. JOURNAL OF HEPATOLOGY
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content
- (2008) B. Ravikumar et al. DIABETES
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search